Plasma osteoprotegerin as a biochemical marker for vascular dementia and Alzheimer's disease.

Enzo Emanuele; Emmanouil Peros; Giuseppe A. Scioli; Angela D'Angelo; Carlo Olivieri; Lorenza Montagna; Diego Geroldi

Plasma osteoprotegerin as a biochemical marker for vascular dementia and Alzheimer's disease.

Enzo Emanuele, Emmanouil Peros, Giuseppe A. Scioli, Angela D'Angelo, Carlo Olivieri, Lorenza Montagna, Diego Geroldi

IRCCS Fondazione Policlinico San Matteo

Research output: Contribution to journal › Article › peer-review

Abstract

Elevated level of osteoprotegerin (OPG), a pleiotropic cytokine involved in bone metabolism, has been associated with coronary heart disease and higher cardiovascular mortality. Because cardiovascular disorders are recognized risk factors for dementia, the study of OPG as a disease marker in vascular dementia (VaD) and Alzheimer's disease (AD) seemed worthy of investigation. OPG concentration was determined by ELISA in an Italian cohort consisting of 39 VaD patients, 36 AD patients, and 39 non-demented controls strictly matched for age and gender. Plasma OPG levels were positively related to age in both demented and non-demented persons. OPG concentrations were significantly higher in both VaD (median: 4.75 pmol/l; interquartile range: 3.42-6.85 pmol/l; P

Original language	English
Pages (from-to)	849-853
Number of pages	5
Journal	International Journal of Molecular Medicine
Volume	13
Issue number	6
Publication status	Published - Jun 2004

ASJC Scopus subject areas

Genetics

Cite this

@article{dd58b18773624e80b4f9e90b594eee35,

title = "Plasma osteoprotegerin as a biochemical marker for vascular dementia and Alzheimer's disease.",

abstract = "Elevated level of osteoprotegerin (OPG), a pleiotropic cytokine involved in bone metabolism, has been associated with coronary heart disease and higher cardiovascular mortality. Because cardiovascular disorders are recognized risk factors for dementia, the study of OPG as a disease marker in vascular dementia (VaD) and Alzheimer's disease (AD) seemed worthy of investigation. OPG concentration was determined by ELISA in an Italian cohort consisting of 39 VaD patients, 36 AD patients, and 39 non-demented controls strictly matched for age and gender. Plasma OPG levels were positively related to age in both demented and non-demented persons. OPG concentrations were significantly higher in both VaD (median: 4.75 pmol/l; interquartile range: 3.42-6.85 pmol/l; P",

author = "Enzo Emanuele and Emmanouil Peros and Scioli, {Giuseppe A.} and Angela D'Angelo and Carlo Olivieri and Lorenza Montagna and Diego Geroldi",

year = "2004",

month = jun,

language = "English",

volume = "13",

pages = "849--853",

journal = "International Journal of Molecular Medicine",

issn = "1107-3756",

publisher = "Spandidos Publications",

number = "6",

}

TY - JOUR

T1 - Plasma osteoprotegerin as a biochemical marker for vascular dementia and Alzheimer's disease.

AU - Emanuele, Enzo

AU - Peros, Emmanouil

AU - Scioli, Giuseppe A.

AU - D'Angelo, Angela

AU - Olivieri, Carlo

AU - Montagna, Lorenza

AU - Geroldi, Diego

PY - 2004/6

Y1 - 2004/6

N2 - Elevated level of osteoprotegerin (OPG), a pleiotropic cytokine involved in bone metabolism, has been associated with coronary heart disease and higher cardiovascular mortality. Because cardiovascular disorders are recognized risk factors for dementia, the study of OPG as a disease marker in vascular dementia (VaD) and Alzheimer's disease (AD) seemed worthy of investigation. OPG concentration was determined by ELISA in an Italian cohort consisting of 39 VaD patients, 36 AD patients, and 39 non-demented controls strictly matched for age and gender. Plasma OPG levels were positively related to age in both demented and non-demented persons. OPG concentrations were significantly higher in both VaD (median: 4.75 pmol/l; interquartile range: 3.42-6.85 pmol/l; P

AB - Elevated level of osteoprotegerin (OPG), a pleiotropic cytokine involved in bone metabolism, has been associated with coronary heart disease and higher cardiovascular mortality. Because cardiovascular disorders are recognized risk factors for dementia, the study of OPG as a disease marker in vascular dementia (VaD) and Alzheimer's disease (AD) seemed worthy of investigation. OPG concentration was determined by ELISA in an Italian cohort consisting of 39 VaD patients, 36 AD patients, and 39 non-demented controls strictly matched for age and gender. Plasma OPG levels were positively related to age in both demented and non-demented persons. OPG concentrations were significantly higher in both VaD (median: 4.75 pmol/l; interquartile range: 3.42-6.85 pmol/l; P

UR - http://www.scopus.com/inward/record.url?scp=7944232938&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=7944232938&partnerID=8YFLogxK

M3 - Article

C2 - 15138623

AN - SCOPUS:7944232938

VL - 13

SP - 849

EP - 853

JO - International Journal of Molecular Medicine

JF - International Journal of Molecular Medicine

SN - 1107-3756

IS - 6

ER -

Plasma osteoprotegerin as a biochemical marker for vascular dementia and Alzheimer's disease.

Abstract

ASJC Scopus subject areas

Other files and links

Fingerprint

Cite this